1. Home
  2. MDBH vs IMRX Comparison

MDBH vs IMRX Comparison

Compare MDBH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDBH
  • IMRX
  • Stock Information
  • Founded
  • MDBH 1997
  • IMRX 2008
  • Country
  • MDBH United States
  • IMRX United States
  • Employees
  • MDBH N/A
  • IMRX N/A
  • Industry
  • MDBH
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDBH
  • IMRX Health Care
  • Exchange
  • MDBH Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • MDBH N/A
  • IMRX 62.7M
  • IPO Year
  • MDBH 2023
  • IMRX 2021
  • Fundamental
  • Price
  • MDBH $6.16
  • IMRX $1.65
  • Analyst Decision
  • MDBH
  • IMRX Strong Buy
  • Analyst Count
  • MDBH 0
  • IMRX 3
  • Target Price
  • MDBH N/A
  • IMRX $11.00
  • AVG Volume (30 Days)
  • MDBH 2.8K
  • IMRX 193.0K
  • Earning Date
  • MDBH 05-12-2025
  • IMRX 03-20-2025
  • Dividend Yield
  • MDBH N/A
  • IMRX N/A
  • EPS Growth
  • MDBH N/A
  • IMRX N/A
  • EPS
  • MDBH N/A
  • IMRX N/A
  • Revenue
  • MDBH $1,937,885.00
  • IMRX N/A
  • Revenue This Year
  • MDBH N/A
  • IMRX N/A
  • Revenue Next Year
  • MDBH N/A
  • IMRX N/A
  • P/E Ratio
  • MDBH N/A
  • IMRX N/A
  • Revenue Growth
  • MDBH N/A
  • IMRX N/A
  • 52 Week Low
  • MDBH $5.78
  • IMRX $1.00
  • 52 Week High
  • MDBH $12.00
  • IMRX $3.83
  • Technical
  • Relative Strength Index (RSI)
  • MDBH 38.62
  • IMRX 46.13
  • Support Level
  • MDBH $6.33
  • IMRX $1.60
  • Resistance Level
  • MDBH $6.52
  • IMRX $1.91
  • Average True Range (ATR)
  • MDBH 0.10
  • IMRX 0.11
  • MACD
  • MDBH -0.03
  • IMRX 0.01
  • Stochastic Oscillator
  • MDBH 0.00
  • IMRX 34.84

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: